Intrinsiqs

Is Medifast, Inc. overvalued?

Medifast, Inc. (MED) — key valuation metrics and fundamentals.

No verdict
Price
$11.44
Fair value
—
Current P/E
—
Normal P/E
22.0
Market cap
$127.2M
Dividend yield
56.6%
Return on equity
-12.7%
Sector
Industrials

See the full interactive analysis →

Fair value compares MED's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks

SPCX Space Exploration Technologies Corp.CAT Caterpillar Inc.GE GE AerospaceRTX RTX CorporationSIEGY Siemens AGEADSY Airbus SE